Reported Earnings • May 19
Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025) Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses. 공시 • May 14
Medix Inc., Annual General Meeting, Jun 26, 2026 Medix Inc., Annual General Meeting, Jun 26, 2026. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥15.00 per share Eligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.0%). Reported Earnings • Feb 11
Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025) Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue. 공시 • Nov 29
Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026 Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026 공시 • Sep 16
Medix Inc. (TSE:331A) announces an Equity Buyback for 600,000 shares, representing 7.47% for ¥308.4 million. Medix Inc. (TSE:331A) announces a share repurchase program. Under the program, the company will repurchase up to 600,000 shares, representing 7.47% of its issued share capital (excluding treasury stock), for a total purchase price of ¥308.4 million. The shares will be repurchased at a price of ¥514 per share. The purpose of the program is to enable flexible capital policies that respond to changes in the business environment. As of September 16, 2025, the company had 8,030,000 issued shares (excluding treasury stock) and 50,000 treasury shares. 공시 • Sep 05
Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million. Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million on September 4, 2025. A cash consideration of TWD 144 million will be paid by Medix Inc. Medix Inc. will pay an earnout payment of TWD 41 million cash. As part of consideration, TWD 185 million is paid towards common equity of Star To Asia Co., Ltd. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is September 30, 2025. The advisory fees is TWD 0.62 million. 공시 • Sep 04
Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025 Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025 공시 • May 31
Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025 Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025 공시 • May 13
Medix Inc., Annual General Meeting, Jun 27, 2025 Medix Inc., Annual General Meeting, Jun 27, 2025. 공시 • Mar 22
Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025 Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025 공시 • Mar 19
Medix Inc. has completed an IPO in the amount of ¥1.84 billion. Medix Inc. has completed an IPO in the amount of ¥1.84 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,800,000
Price\Range: ¥800
Discount Per Security: ¥64
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 500,000
Price\Range: ¥800
Discount Per Security: ¥64